MEDICARE PART D ENROLLEES' USE OF OUT-OF-PLAN DISCOUNTED GENERIC DRUGS, REVISITED

被引：4
|
作者：
Harding, Jonathan [1 ]
机构：
[1] Tufts Hlth Plan, Watertown, MA USA
来源：
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 2013年 / 61卷 / 02期
关键词：
D O I：
10.1111/jgs.12076
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：309 / 310
页数：2
相关论文
共 50 条
  • [21] Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part D
    Dusetzina, Stacie B.
    Sarpatwari, Ameet
    Carrier, Michael A.
    Hansen, Richard A.
    Keating, Nancy L.
    Huskamp, Haiden A.
    JAMA INTERNAL MEDICINE, 2021, 181 (12) : 1605 - 1611
  • [22] The Impact of the Medicare Part D Prescription Benefit on Generic Drug Use
    James X. Zhang
    Wesley Yin
    Shawn X. Sun
    G. Caleb Alexander
    Journal of General Internal Medicine, 2008, 23 : 1673 - 1678
  • [23] The impact of the Medicare Part D prescription benefit on generic drug use
    Zhang, James X.
    Yin, Wesley
    Sun, Shawn X.
    Alexander, G. Caleb
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 (10) : 1673 - 1678
  • [24] Increasing generic drug use in medicare part D: The role of government
    Kohl, Herb
    Shrank, William H.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (07) : 1106 - 1109
  • [25] Drug Coverage and Decision Making in Medicare Part D Enrollees
    Hales, John W.
    Mills, Karmardi
    Hegamin, Angela P.
    Poulios, Nick S.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2011, 3 (04) : 221 - 228
  • [26] Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer
    Adams, Alyce S.
    Madden, Jeanne M.
    Zhang, Fang
    Lu, Christine Y.
    Ross-Degnan, Dennis
    Lee, Angelina
    Soumerai, Stephen B.
    Gilden, Dan
    Chawla, Neetu
    Griggs, Jennifer J.
    VALUE IN HEALTH, 2017, 20 (10) : 1345 - 1354
  • [27] Effects of Medicare Part D coverage gap closure on utilization of branded and generic drugs
    Liu, Judith
    Zhang, Yuting
    Kaplan, Cameron M.
    HEALTH ECONOMICS, 2023, 32 (03) : 639 - 653
  • [28] The Introduction of Generic Aromatase Inhibitors and Treatment Adherence Among Medicare D Enrollees
    Neuner, Joan M.
    Kamaraju, Sailaja
    Charlson, John A.
    Wozniak, Erica M.
    Smith, Elizabeth C.
    Biggers, Alana
    Smallwood, Alicia J.
    Laud, Purushottam W.
    Pezzin, Liliana E.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (08):
  • [29] The Introduction of Generic Risperidone in Medicare Part D
    Fung, Vicki
    Price, Mary
    Busch, Alisa B.
    Landrum, Mary Beth
    Fireman, Bruce
    Nierenberg, Andrew A.
    Newhouse, Joseph P.
    Hsu, John
    AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 (01): : 41 - +
  • [30] Generic alendronate use among medicare beneficiaries: are part d data complete?
    Yun, Huifeng
    Curtis, Jeffrey R.
    Saag, Kenneth
    Kilgore, Meredith
    Muntner, Paul
    Smith, Wilson
    Matthews, Robert
    Wright, Nicole
    Morrisey, Michael A.
    Delzell, Elizabeth
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (01) : 55 - 63
12345